PharmaTech
JUNE 10, 2025
s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry June 10, 2025 By Christopher Cole News Article The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond. On June 9, 2025, Secretary of Health and Human Services Robert F. June 9, 2025.
PharmaTech
JUNE 19, 2025
Image Credit: © Cagkan - © Cagkan - stock.adobe.com BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. June 17, 2025. Pharmaceutical Technology 2025 49 (4). Communication between the manufacturing plant and retail stores. Press Release. Haigney, S. link] Thomas, F.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
DECEMBER 19, 2024
The new manufacturing lines will be operational in phases, with existing lines at the Suzhou and Rewari sites already functional since Q4 2024, and additional lines expected to start operations by Q3 2025. Thanks to their favorable dissolution rates, these capsules are valuable for developers of medicines and nutraceuticals.
FDA Law Blog: Biosimilars
MAY 19, 2025
Attorneys Office, Northern District of Illinois, April 21, 2025. Opioid prescriptions for high dosages and quantities, including prescriptions that individually or in combination, provide patients with daily dosages of greater than or equal to 300 Morphine Milligram Equivalents (MMEs). 81, 89, 251.
Big Molecule Watch
JUNE 23, 2025
On June 15, 2025, Celltrion announced that the FDA has approved a new 45mg/0.5mL single-dose vial presentation of STEQEYMA (ustekinumab-stba) for subcutaneous injection. According to Celltrion, the new dosage form is intended to give physicians more flexibility while maintaining STEQEYMA’s safety and efficacy.
PharmaTech
JUNE 19, 2025
European geopolitical shifts In two installments of Pharmaceutical Technology ®’s “Industry Outlook 2025” series, Alexander Seyf, CEO and co-founder of Autolomous, and Edwin Stone, CEO of Cellular Origins, discussed European political impacts on the pharmaceutical industry at large, and the pharma supply chain in particular. June 12, 2025.
European Pharmaceutical Review
NOVEMBER 1, 2024
billion in 2025 to approximately $174.45 Packaging types generating demand in the market include tamper-proofing drug packaging against counterfeiting, as well as single-dosage packaging, according to the research. The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12
Expert insights. Personalized for you.
85 
Let's personalize your content